Allied Market Research recently published a report, titled, “Syphilis Testing Market by By Type (Primary & Secondary Syphilis, Others), by Location of Testing (Laboratory testing, Point of care (POC) testing): Global Opportunity Analysis and Industry Forecast, 2020-2030.” According to the report, the global syphilis testing industry was pegged at $1.1 billion in 2020, and is expected to reach $1.9 billion by 2030, growing at a CAGR of 5.6% from 2021 to 2030.
Syphilis is a sexually transmitted infection caused by bacteria, Treponema pallidium. It is most infectious in the first two stages. The first stage of syphilis is in the hidden, or latent, stage, at which it will not harm the patient. The disease remains active but there are no symptoms. The second stage is called as tertiary syphilis, which is most destructive to health.
Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/675
Drivers, restraints, and opportunities-
Increase in the occurrence of sexually transmitted disease including syphilis and technological advancements drive the growth of syphilis testing market. However, high proportion of health and economic burden for the developing countries due to Syphilis and avoidance and refraining from voluntary / CICT Syphilis testing hinder the uptake of diagnostic tests or testing volume, thus restraining the growth of the syphilis testing market. Moreover, rapid development in diagnostic kits, improved healthcare infrastructure, and availability of test kits are expected to create opportunities for market growth during the forecast period.
COVID-19 scenario-
- The outbreak of the Covid-19 pandemic negatively impacted the global syphilis testing market. This is owing to decrease in the number of patient visits to hospitals and clinics for testing, as a result of the suspension of various elective procedures and outpatient visits, which reduced the demand for syphilis tests.
- Between March 2019 and May 2020, the Syphilis testing rate fell by 64%.
The primary & secondary syphilis segment to dominate by 2030-
By type, the primary & secondary syphilis segment accounted for nearly two-thirds of the global syphilis testing market share in 2020, and is anticipated to retain its dominance throughout the forecast period. This is attributed to increase in syphilis infection rate, availability of screening test such as automated treponemal tests (TTs) that includes enzyme immune-assays (EIAs) under primary syphilis & RPR card, the serological test VDRL, and USR for secondary syphilis. Moreover, the same segment would showcase the fastest CAGR of 5.7% by 2030.
Specific Requirement on COVID-19? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/675
The laboratory testing segment held the lion’s share in 2020-
Based on location of testing, the laboratory testing segment held the lion’s share in 2020, contributing to more than four-fifths of the global syphilis testing market, and is expected to continue its lead during the forecast period. However, thepoint of care (POC) testing segment is expected to witness the highest CAGR of 6.8% by 2030, due to increase in prevalence of syphilis infection, the laboratory test is cost efficient, convenient and confidential for use in hospitals & clinics.
North America, to lead the trail in terms of revenue-
By region, North America, garnered the major share in 2020, contributing to more than one-third of the global syphilis testing market and is expected to dominate the market during the forecast period. However, LAMEA region is expected grow at the fastest CAGR of 6.2% by 2030.
Leading market players-
Becton Dickinson And Company
Hologic, Inc.
Cepheid Inc.
DiaSorin
Abbott Laboratories
Bio-Rad Laboratories
Beckman Coulter Inc
F. Hoffmann-La Roche
Affymetrix, Inc
Siemens healthcare
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter
“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”
About Us:
Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975